GlassScriptPhysician profile
Diego J Gonzalez
NPI 1194715938
$34,593.95
in general payments reported to CMS, 2019-2025
24 companies · $2,792 in 2025
The $2,792 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,214 · 2020: $5,379 · 2021: $3,433 · 2022: $14K · 2023: $4,544 · 2024: $3,609 · 2025: $2,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,942 · Travel and Lodging: $4,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,941.77 |
| Travel and Lodging | $4,003.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,705.74 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Nevro Corp. | $6,414.81 | 2019-2024 | Senza |
| Nalu Medical, INC. | $2,450.56 | 2021-2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $2,247.79 | 2019-2025 | Intracept, General - Pain Management |
| Medtronic USA, INC. | $1,884.11 | 2019-2020 | |
| Orthofix Medical, INC. | $1,319.31 | 2023 | Forza, Firebird, Sambascrew |
| Relievant Medsystems, INC. | $1,164.90 | 2021-2023 | Intracept |
| Globus Medical, INC. | $633.00 | 2025 | Senza, Vyrsa V1 |
| Biodelivery Sciences International, INC. | $129.47 | 2020-2021 | |
| Stryker Corporation | $122.60 | 2020 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $63.65 | 2021-2022 | |
| Si-Bone, INC. | $63.61 | 2024 | |
| Baxter Healthcare | $43.36 | 2019-2025 | Perclot |
| Piramal Critical Care | $39.17 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $36.22 | 2019 | |
| Grt US Holding, INC. | $34.49 | 2022 | |
| Daiichi Sankyo INC. | $31.41 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.46 | 2019 | |
| Collegium Pharmaceutical, INC. | $21.35 | 2020 | |
| Avanos Medical | $19.17 | 2025 | Generator |
| Teva Pharmaceuticals USA, INC. | $17.40 | 2019 | |
| Mdd US Operations, LLC | $14.62 | 2019 | |
| Bioventus LLC | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.